Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duodenal Levodopa Infusion in Advanced Parkinson's Disease
NCT00914134Phase 4Completed
- Sponsor
- University of Helsinki
- Start
- Apr 2009
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of levodopa in Parkinson's disease (PD), sponsored by University of Helsinki. Primary endpoint: Orthostatic blood pressure change at 2 months. Started Apr 2009; status: completed.
02
Drugs
levodopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00914134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00914134.